QTRX (STOCKS)
Quanterix Corporation Common Stock
$3.100000
+0.000000 (+0.00%)
Prev close: $3.100000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Everett V. Cunningham
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $146.50M
- Employees
- 136
- P/E (TTM)
- -1.31
- P/B (TTM)
- 0.52
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
5
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.37 | $-0.55 | +0.1842 | +33.24% |
|
Dec 2025 (Q4)
|
$-0.49 | $-0.46 | -0.0310 | -6.75% |
|
Sep 2025 (Q3)
|
$-0.73 | $-0.54 | -0.1894 | -35.04% |
|
Jun 2025 (Q2)
|
$-0.57 | $-0.37 | -0.2028 | -55.23% |
Financial Statements
| Revenues | $144.98M |
| Benefits Costs and Expenses | $251.38M |
| Cost Of Revenue | $80.87M |
| Costs And Expenses | $251.38M |
| Gross Profit | $64.11M |
| Operating Expenses | $204.65M |
| Selling, General, and Administrative Expenses | $135.32M |
| Research and Development | $33.21M |
| Other Operating Expenses | $36.12M |
| Operating Income/Loss | -$140.54M |
| Income/Loss From Continuing Operations After Tax | -$104.19M |
| Income/Loss From Continuing Operations Before Tax | -$106.40M |
| Income Tax Expense/Benefit | -$2.22M |
| Interest Income/Expense After Provision For Losses | $4.66M |
| Interest Income/Expense Operating, Net | $6.19M |
| Net Income/Loss | -$104.19M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$104.19M |
| Net Income/Loss Available To Common Stockholders, Basic | -$104.19M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $1.53M |
| Basic Earnings Per Share | -$2.34 |
| Diluted Earnings Per Share | -$2.34 |
| Basic Average Shares | 133,328,000 |
| Diluted Average Shares | 133,328,000 |
| Assets | $366.67M |
| Current Assets | $185.73M |
| Inventory | $50.96M |
| Other Current Assets | $134.77M |
| Noncurrent Assets | $180.95M |
| Fixed Assets | $21.37M |
| Intangible Assets | $109.16M |
| Other Non-current Assets | $50.42M |
| Liabilities | $84.53M |
| Current Liabilities | $49.91M |
| Accounts Payable | $8.66M |
| Other Current Liabilities | $41.25M |
| Noncurrent Liabilities | $34.63M |
| Equity | $282.14M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $282.14M |
| Liabilities And Equity | $366.67M |
| Net Cash Flow From Operating Activities | -$81.46M |
| Net Cash Flow From Operating Activities, Continuing | -$81.46M |
| Net Cash Flow From Investing Activities | $42.73M |
| Net Cash Flow From Investing Activities, Continuing | $42.73M |
| Net Cash Flow From Financing Activities | -$1.57M |
| Net Cash Flow From Financing Activities, Continuing | -$1.57M |
| Exchange Gains/Losses | $673.00K |
| Net Cash Flow | -$39.62M |
| Net Cash Flow, Continuing | -$40.29M |
| Comprehensive Income/Loss | -$104.27M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$103.38M |
| Other Comprehensive Income/Loss | -$33.60M |
| Other Comprehensive Income/Loss Attributable To Parent | $808.00K |